Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2005
03/17/2005WO2004019761A3 Methods of treating age-related defects and diseases
03/17/2005WO2004016761A3 Gene therapy for critical limb ischemia with wild type or mutant enos
03/17/2005WO2003061564A8 Gene expression profiles in liver disease
03/17/2005WO2003011898A3 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
03/17/2005US20050060762 Plasmid construct comprising hybrid alpha -lactalbumin promoter for use as gene transfer and expression tool in genetic engineering; gene therapy and tissue engineering
03/17/2005US20050059999 Delivering genetic material to a stimulation site
03/17/2005US20050059815 Processes for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom
03/17/2005US20050059807 Transcriptional modulator for use in the treatment and prevention of cell proliferative, muscular, blood, gastrointestinal and cardiovascular disorders
03/17/2005US20050059627 Administering antisense oligonucleotides against the mRNA of corticotropin releasing factor subtype-2 (CRF2) receptor; treating anxiety, obsessive-compulsive disorder, panic disorders, post-traumatic stress, phobias and depression
03/17/2005US20050059625 Immunostimulatory nucleic acid molecules
03/17/2005US20050059623 linking chaperone protein promoters to genetically engineered genes, then heating
03/17/2005US20050059621 preventing apoptosis in neurons that occurs in the presence of beta -amyloid protein, during or after hypoxia or when the neuron exhibits an elevated intracellular calcium concentrations, comprising administering tyrosine kinase inhibitors; treating neurodegenerative diseases
03/17/2005US20050059619 Immunostimulatory nucleic acids
03/17/2005US20050059618 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
03/17/2005US20050059596 Modulating response to genotoxic stress
03/17/2005US20050059586 For increasing expression of human presenilin; for treatment of neurodegenerative diseases, Alzheimer's disease; drug screening
03/17/2005US20050059144 MHC class II antigen-presenting systems and methods for activating CD4+ T cells
03/17/2005US20050059121 Colony stimualting factor for use in animal vaccination and as nonspecific immunity stimulant; veterinary medicine
03/17/2005US20050059118 Hyaluronan receptor for endocytosis
03/17/2005US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
03/17/2005US20050059109 Methods and compositions for polypeptide engineering
03/17/2005US20050059108 Expression vector comprising nucleotide sequences coding neurotransmitter for use in prevention and treatment of obesity, anorexia, energy imbalance, diabetes, dyslipidemia, hypertension and/or insulin resistance
03/17/2005US20050059079 Expression vector comprising nucleotide sequences associated with neuropsychological disruption for use in diagnosis, prevention and treatment of schizophrenia, mood and bipolar disorders
03/17/2005US20050059073 Expression vector comprising nucleotide sequences coding cell growth factors for use in treatment and prevention of nervous system disorders
03/17/2005US20050059067 Using restriction fragment length polymorphism in tyrosine kinase varian t as diagnostic tool in detection of cell proliferative and inflammatory disorders
03/17/2005US20050059044 Small interfering RNA sequences for use as gene silencing tools; gene expression inhibition
03/17/2005US20050059028 RNAi-based sensors, caged interfering RNAs, and methods of use thereof
03/17/2005US20050059016 Structural motifs and oligomeric compounds and their use in gene modulation
03/17/2005US20050059008 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
03/17/2005US20050059005 Microrna molecules
03/17/2005US20050058999 Gene involved in apoptosis regulation
03/17/2005US20050058661 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus Borrelia
03/17/2005US20050058657 Vaccines for treatment of Aids
03/17/2005US20050058653 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
03/17/2005US20050058626 Vaccine against pathogens
03/17/2005US20050058623 Use of gp130 activators in diabetic neuropathy
03/17/2005CA2538174A1 Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
03/17/2005CA2537953A1 Lentivirus vector-based approaches for generating an immune response to hiv in humans
03/17/2005CA2536015A1 Modified oligonucleotides for telomerase inhibition
03/17/2005CA2535770A1 Method for detecting cancer cells and monitoring cancer therapy
03/16/2005EP1514558A1 Use of MARKK or MARKK antagonists for the treatment of pathologies characterised by increased or reduced phosphorylation of MARK or tau protein
03/16/2005EP1513875A2 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
03/16/2005EP1513870A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
03/16/2005EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/16/2005EP1513859A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
03/16/2005EP1513853A2 Cardiolipin compositions, methods of preparation and use
03/16/2005EP1513559A1 Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system
03/16/2005EP1513558A2 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1alpha
03/16/2005EP1513553A1 Methods and materials for treating inflammatory conditions
03/16/2005EP1513545A2 Methods and means to promote gut absorption
03/16/2005EP1513538A2 Novel methods for the delivery of polynucleotides to cells
03/16/2005EP1513506A1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof
03/16/2005EP1513404A1 Intramyocardial injection of autologous bone marrow
03/16/2005EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof
03/16/2005EP1250358B1 Therapeutic peptides
03/16/2005EP1165134B1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
03/16/2005EP0948609B1 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
03/16/2005EP0861329B1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof
03/16/2005EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides
03/16/2005CN1596305A Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
03/16/2005CN1596303A Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
03/16/2005CN1596269A A novel G protein-coupled receptor, gave 10
03/16/2005CN1596130A Genetic remedies for neurodegenerative diseases
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596121A Prevention and treatment of restenosis by local administration of drug
03/16/2005CN1594587A Preparation for fungus extracellular polysaccharide compound and application thereof
03/16/2005CN1594567A Immune tbid gene, encoded protein and use thereof
03/16/2005CN1594552A Protein conformational disease cell model and its use
03/16/2005CN1594347A Gene therapeutic drug hdm2-siRNA for breast cancer
03/16/2005CN1593663A Target directional DNA vaccine for preventing caries and preparation method thereof
03/16/2005CN1593662A Target directional confluent DNA vaccine for preventing caries and preparation method thereof
03/16/2005CN1593462A Insulin secretory cell extract and its application in inducing stem cell differentiation
03/16/2005CN1193096C Operation for onzyme activity of protoporphyrin prooxidase in eukaryotic organism
03/16/2005CN1193095C Complex
03/16/2005CN1193094C Antigenic proteins of shrimp white spot syndrome virus and uses thereof
03/15/2005US6867288 Polycystic kidney disease gene
03/15/2005US6867231 Therapeutic systems
03/15/2005US6867227 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind the DNA minor groove as a dimer
03/15/2005US6867197 Method of targeting conjugate molecules to mitochondria
03/15/2005US6867196 Injecting into blood vessel near or in heart muscle; limiting invasiveness
03/15/2005US6867195 In vivo translation delivering antisense nucleotides; elicit-ing immune response to poorly immunogenic viral proteins
03/15/2005US6867043 Controlling gene expression in cells; anticancer agents; drug delivery
03/15/2005US6867039 Oligonucleotides, specifically hybridizable with nucleic acids encoding dual specific phosphatase 5
03/15/2005US6867022 Replication deficient adenovirus vectors and methods of making and using them
03/15/2005US6866854 Spliced gene of KSHV/HHV8, its promoter and monoclonal antibodies specific for LANA2
03/15/2005US6866851 GFRα1-RET specific agonists and methods therefor
03/15/2005US6866843 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
03/15/2005US6866842 Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
03/15/2005US6866838 Composite nanospheres and their conjugates with biomolecules
03/15/2005CA2054325C Antisense oligonucleotides for treatment of cancer
03/10/2005WO2005021768A1 Aav vectors for in vivo gene therapy of rheumatoid arthritis
03/10/2005WO2005021751A1 A self-processing rna expression cassette
03/10/2005WO2005021749A1 Interfering rna duplex having blunt-ends and 3’-modifications
03/10/2005WO2005021746A1 Recombinant virus vector originating in hhv-6 or hhv-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same
03/10/2005WO2005021716A2 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
03/10/2005WO2005021583A2 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β
03/10/2005WO2005021045A1 Gene therapy for skin diseases using needle free syringe
03/10/2005WO2005020916A2 Myoblast treatment of diseased or weakened organs
03/10/2005WO2005020902A2 Compositions and methods for treating and diagnosing irritable bowel syndrome
03/10/2005WO2005020892A2 Pharmaceutical compositions and methods for metabolic modulation
1 ... 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 ... 870